Treatment with exenatide BID and QW for 30 weeks was associated with favourable lipid subclass changes Conference

Chilton, R, Toth, P, Ramirez, G et al. (2011). Treatment with exenatide BID and QW for 30 weeks was associated with favourable lipid subclass changes . DIABETOLOGIA, 54 S324-S324.

Industry Collaboration

cited authors

  • Chilton, R; Toth, P; Ramirez, G; Cobble, M; Walsh, B; Chiquette, E

authors

date/time interval

  • September 12, 2011 -

publication date

  • September 1, 2011

webpage

published in

keywords

  • Endocrinology & Metabolism
  • Life Sciences & Biomedicine
  • Science & Technology

Location

  • Lisbon, PORTUGAL

Conference

  • 47th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)

publisher

  • SPRINGER

start page

  • S324

end page

  • S324

volume

  • 54